-
3
-
-
84963018413
-
A practical treatise on nervous exhaustion, (neurasthenia); Its symptoms
-
W Wood & Company
-
Beard, G. M. A Practical Treatise on Nervous Exhaustion, (Neurasthenia); Its Symptoms, Nature, Sequences, Treatment. (W. Wood & Company, 1880).
-
(1880)
Nature, Sequences, Treatment
-
-
Beard, G.M.1
-
5
-
-
1542297793
-
The assessment of fatigue: A practical guide for clinicians and researchers
-
Dittner, A. J., Wessely, S. C. & Brown, R. G. The assessment of fatigue: A practical guide for clinicians and researchers. J. Psychosom. Res. 56, 157-170 (2004).
-
(2004)
J. Psychosom. Res.
, vol.56
, pp. 157-170
-
-
Dittner, A.J.1
Wessely, S.C.2
Brown, R.G.3
-
6
-
-
1642333956
-
Fatigue in neurological disorders
-
Chaudhuri, A. & Behan, P. O. Fatigue in neurological disorders. Lancet 363, 978-988 (2004).
-
(2004)
Lancet
, vol.363
, pp. 978-988
-
-
Chaudhuri, A.1
Behan, P.O.2
-
7
-
-
84873623522
-
Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy
-
Kluger, B. M., Krupp, L. B. & Enoka, R. M. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology 80, 409-416 (2013).
-
(2013)
Neurology
, vol.80
, pp. 409-416
-
-
Kluger, B.M.1
Krupp, L.B.2
Enoka, R.M.3
-
8
-
-
0242288106
-
Levodopa improves physical fatigue in Parkinson's disease: A double-blind, placebo-controlled, crossover study
-
Lou, J. S. et al. Levodopa improves physical fatigue in Parkinson's disease: A double-blind, placebo-controlled, crossover study. Mov. Disord. 18, 1108-1114 (2003).
-
(2003)
Mov. Disord.
, vol.18
, pp. 1108-1114
-
-
Lou, J.S.1
-
9
-
-
33846523586
-
The relationship between subjective fatigue and cognitive fatigue in advanced multiple sclerosis
-
Bailey, A., Channon, S. & Beaumont, J. G. The relationship between subjective fatigue and cognitive fatigue in advanced multiple sclerosis. Mult. Scler. 13, 73-80 (2007).
-
(2007)
Mult. Scler.
, vol.13
, pp. 73-80
-
-
Bailey, A.1
Channon, S.2
Beaumont, J.G.3
-
10
-
-
0034633712
-
Fatigue and declines in cognitive functioning in multiple sclerosis
-
Krupp, L. B. & Elkins, L. E. Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 55, 934-939 (2000).
-
(2000)
Neurology
, vol.55
, pp. 934-939
-
-
Krupp, L.B.1
Elkins, L.E.2
-
11
-
-
0030873086
-
Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A 18F-fluorodeoxyglucose positron emission tomography study
-
Roelcke, U. et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A 18F-fluorodeoxyglucose positron emission tomography study. Neurology 48, 1566-1571 (1997).
-
(1997)
Neurology
, vol.48
, pp. 1566-1571
-
-
Roelcke, U.1
-
12
-
-
0036339422
-
Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis
-
Filippi, M. et al. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 15, 559-567 (2002).
-
(2002)
Neuroimage
, vol.15
, pp. 559-567
-
-
Filippi, M.1
-
13
-
-
29644442602
-
Fatigue in multiple sclerosis: An example of cytokine mediated sickness behaviour
-
Heesen, C. et al. Fatigue in multiple sclerosis: An example of cytokine mediated sickness behaviour J. Neurol. Neurosurg. Psychiatry 77, 34-39 (2006).
-
(2006)
J. Neurol. Neurosurg. Psychiatry
, vol.77
, pp. 34-39
-
-
Heesen, C.1
-
14
-
-
13444302611
-
Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis
-
Gottschalk, M. et al. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch. Neurol. 62, 277-280 (2005).
-
(2005)
Arch. Neurol.
, vol.62
, pp. 277-280
-
-
Gottschalk, M.1
-
15
-
-
33746564555
-
Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone
-
Téllez, N. et al. Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone. Mult. Scler. 12, 487-494 (2006).
-
(2006)
Mult. Scler.
, vol.12
, pp. 487-494
-
-
Téllez, N.1
-
16
-
-
84887621358
-
Treatment of sleep disorders may improve fatigue in multiple sclerosis
-
Veauthier, C. et al. Treatment of sleep disorders may improve fatigue in multiple sclerosis. Clin. Neurol. Neurosurg. 115, 1826-1830 (2013).
-
(2013)
Clin. Neurol. Neurosurg.
, vol.115
, pp. 1826-1830
-
-
Veauthier, C.1
-
17
-
-
80053402234
-
Fatigue in multiple sclerosis is closely related to sleep disorders: A polysomnographic cross-sectional study
-
Veauthier, C. et al. Fatigue in multiple sclerosis is closely related to sleep disorders: A polysomnographic cross-sectional study. Mult. Scler. 17, 613-622 (2011).
-
(2011)
Mult. Scler.
, vol.17
, pp. 613-622
-
-
Veauthier, C.1
-
18
-
-
33746493300
-
Sleep and fatigue in multiple sclerosis
-
Stanton, B. R., Barnes, F. & Silber, E. Sleep and fatigue in multiple sclerosis. Mult. Scler. 12, 481-486 (2006).
-
(2006)
Mult. Scler.
, vol.12
, pp. 481-486
-
-
Stanton, B.R.1
Barnes, F.2
Silber, E.3
-
19
-
-
0023795328
-
Chronic fatigue in primary care prevalence, patient characteristics, and outcome
-
Kroenke, K., Wood, D. R., Mangelsdorff, A. D., Meier, N. J. & Powell, J. B. Chronic fatigue in primary care. prevalence, patient characteristics, and outcome. JAMA 260, 929-934 (1988).
-
(1988)
JAMA
, vol.260
, pp. 929-934
-
-
Kroenke, K.1
Wood, D.R.2
Mangelsdorff, A.D.3
Meier, N.J.4
Powell, J.B.5
-
20
-
-
0141523110
-
Chronic fatigue and sociodemographic characteristics as predictors of psychiatric disorders in a community-based sample
-
Taylor, R. R., Jason, L. A. & Jahn, S. C. Chronic fatigue and sociodemographic characteristics as predictors of psychiatric disorders in a community-based sample. Psychosom. Med. 65, 896-901 (2003).
-
(2003)
Psychosom. Med.
, vol.65
, pp. 896-901
-
-
Taylor, R.R.1
Jason, L.A.2
Jahn, S.C.3
-
21
-
-
44449151576
-
The relationship between prior psychiatric disorder and chronic fatigue: Evidence from a national birth cohort study
-
Harvey, S. B., Wadsworth, M., Wessely, S. & Hotopf, M. The relationship between prior psychiatric disorder and chronic fatigue: evidence from a national birth cohort study. Psychol. Med. 38, 933-940 (2008).
-
(2008)
Psychol. Med.
, vol.38
, pp. 933-940
-
-
Harvey, S.B.1
Wadsworth, M.2
Wessely, S.3
Hotopf, M.4
-
22
-
-
0003472502
-
-
American Psychiatric Association. 5th edn (American Psychiatric Publishing
-
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Publishing, 2013).
-
(2013)
Diagnostic and Statistical Manual of Mental Disorders
-
-
-
23
-
-
84983393043
-
Co occurrence and symptomatology of fatigue and depression
-
Corfield, E. C., Martin, N. G. & Nyholt, D. R. Co occurrence and symptomatology of fatigue and depression. Compr. Psychiatry 71, 1-10 (2016).
-
(2016)
Compr. Psychiatry
, vol.71
, pp. 1-10
-
-
Corfield, E.C.1
Martin, N.G.2
Nyholt, D.R.3
-
24
-
-
0034904033
-
Epidemiology of unexplained fatigue and major depression in the community: The Baltimore ECA follow up, 1981-1994
-
Addington, A. M., Gallo, J. J., Ford, D. E. & Eaton, W. W. Epidemiology of unexplained fatigue and major depression in the community: The Baltimore ECA follow up, 1981-1994. Psychol. Med. 31, 1037-1044 (2001).
-
(2001)
Psychol. Med.
, vol.31
, pp. 1037-1044
-
-
Addington, A.M.1
Gallo, J.J.2
Ford, D.E.3
Eaton, W.W.4
-
25
-
-
0042307335
-
Serotonin and the neuroendocrine regulation of the hypothalamic-pituitary-adrenal axis in health and disease
-
Hanley, N. S. & Van de Kar, L. D. Serotonin and the neuroendocrine regulation of the hypothalamic-pituitary-adrenal axis in health and disease. Vitam. Horm. 66, 189-255 (2003).
-
(2003)
Vitam. Horm.
, vol.66
, pp. 189-255
-
-
Hanley, N.S.1
Van De Kar, L.D.2
-
26
-
-
84947875160
-
Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease
-
Qamhawi, Z. et al. Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease. Brain 138, 2964-2973 (2015).
-
(2015)
Brain
, vol.138
, pp. 2964-2973
-
-
Qamhawi, Z.1
-
27
-
-
36849068377
-
Origin of fatigue in multiple sclerosis: Review of the literature
-
Kos, D., Kerckhofs, E., Nagels, G., D'hooghe, M. B. & Ilsbroukx, S. Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil. Neural Repair 22, 91-100 (2007).
-
(2007)
Neurorehabil. Neural Repair
, vol.22
, pp. 91-100
-
-
Kos, D.1
Kerckhofs, E.2
Nagels, G.3
D'Hooghe, M.B.4
Ilsbroukx, S.5
-
28
-
-
37249094173
-
From inflammation to sickness and depression: When the immune system subjugates the brain
-
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W. & Kelley, K. W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46-56 (2008).
-
(2008)
Nat. Rev. Neurosci.
, vol.9
, pp. 46-56
-
-
Dantzer, R.1
O'Connor, J.C.2
Freund, G.G.3
Johnson, R.W.4
Kelley, K.W.5
-
29
-
-
68049131222
-
Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity
-
Harrison, N. A. et al. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol. Psychiatry 66, 407-414 (2009).
-
(2009)
Biol. Psychiatry
, vol.66
, pp. 407-414
-
-
Harrison, N.A.1
-
30
-
-
84920933457
-
The representation of inflammatory signals in the brain -a model for subjective fatigue in multiple sclerosis
-
Hanken, K., Eling, P. & Hildebrandt, H. The representation of inflammatory signals in the brain -a model for subjective fatigue in multiple sclerosis. Front. Neurol. 5, 264 (2014).
-
(2014)
Front. Neurol.
, vol.5
, pp. 264
-
-
Hanken, K.1
Eling, P.2
Hildebrandt, H.3
-
31
-
-
84998854189
-
The Berlin treatment algorithm Recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue
-
Veauthier, C. The Berlin treatment algorithm. Recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue. EPMA J. 7, 25 (2016).
-
(2016)
EPMA J.
, vol.7
, pp. 25
-
-
Veauthier, C.1
-
32
-
-
79959864896
-
Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression
-
Gold, S. M. et al. Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression. J. Neurol. Neurosurg. Psychiatry 82, 814-818 (2011).
-
(2011)
J. Neurol. Neurosurg. Psychiatry
, vol.82
, pp. 814-818
-
-
Gold, S.M.1
-
33
-
-
84927702971
-
Circadian cortisol and fatigue severity in relapsing-remitting multiple sclerosis
-
Powell, D. J. H., Moss-Morris, R., Liossi, C. & Schlotz, W. Circadian cortisol and fatigue severity in relapsing-remitting multiple sclerosis. Psychoneuroendocrinology 56, 120-131 (2015).
-
(2015)
Psychoneuroendocrinology
, vol.56
, pp. 120-131
-
-
Powell, D.J.H.1
Moss-Morris, R.2
Liossi, C.3
Schlotz, W.4
-
34
-
-
77950885206
-
Relationship of cortical atrophy to fatigue in patients with multiple sclerosis
-
Pellicano, C. et al. Relationship of cortical atrophy to fatigue in patients with multiple sclerosis. Arch. Neurol. 67, 447-453 (2010).
-
(2010)
Arch. Neurol.
, vol.67
, pp. 447-453
-
-
Pellicano, C.1
-
35
-
-
83255186679
-
Fatigue and progression of corpus callosum atrophy in multiple sclerosis
-
Yaldizli, Ö. et al. Fatigue and progression of corpus callosum atrophy in multiple sclerosis. J. Neurol. 258, 2199-2205 (2011).
-
(2011)
J. Neurol.
, vol.258
, pp. 2199-2205
-
-
Yaldizli, Ö.1
-
36
-
-
84895743885
-
The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients
-
Yaldizli, Ö. et al. The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients. Mult. Scler. 20, 356-364 (2014).
-
(2014)
Mult. Scler.
, vol.20
, pp. 356-364
-
-
Yaldizli, Ö.1
-
37
-
-
84992111568
-
The impact of MS related cognitive fatigue on future brain parenchymal loss and relapse: A 17 month follow up study
-
Sander, C. et al. The impact of MS related cognitive fatigue on future brain parenchymal loss and relapse: A 17 month follow up study. Front. Neurol. 7, 155 (2016).
-
(2016)
Front. Neurol.
, vol.7
, pp. 155
-
-
Sander, C.1
-
38
-
-
61849169991
-
Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways
-
Sepulcre, J. et al. Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways. Mult. Scler. 15, 337-344 (2008).
-
(2008)
Mult. Scler.
, vol.15
, pp. 337-344
-
-
Sepulcre, J.1
-
39
-
-
77953739225
-
Frontal networks play a role in fatigue perception in multiple sclerosis
-
Pardini, M., Bonzano, L., Mancardi, G. L. & Roccatagliata, L. Frontal networks play a role in fatigue perception in multiple sclerosis. Behav. Neurosci. 124, 329 (2010).
-
(2010)
Behav. Neurosci.
, vol.124
, pp. 329
-
-
Pardini, M.1
Bonzano, L.2
Mancardi, G.L.3
Roccatagliata, L.4
-
40
-
-
85007566083
-
Abnormal resting-state neural activity and connectivity of fatigue in Parkinson's disease
-
Zhang, J. J. et al. Abnormal resting-state neural activity and connectivity of fatigue in Parkinson's disease. CNS Neurosci. Ther. 23, 241-247 (2017).
-
(2017)
CNS Neurosci. Ther.
, vol.23
, pp. 241-247
-
-
Zhang, J.J.1
-
41
-
-
84994626508
-
Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigue
-
Pravatà, E. et al. Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigue. Mult. Scler. 13, 1665-1675 (2016).
-
(2016)
Mult. Scler.
, vol.13
, pp. 1665-1675
-
-
Pravatà, E.1
-
42
-
-
84930386562
-
Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue
-
Finke, C. et al. Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue. Mult. Scler. 21, 925-934 (2015).
-
(2015)
Mult. Scler.
, vol.21
, pp. 925-934
-
-
Finke, C.1
-
43
-
-
84935909672
-
Factors associated with poststroke fatigue: A systematic review
-
Ponchel, A., Bombois, S., Bordet, R. & Hénon, H. Factors associated with poststroke fatigue: A systematic review. Stroke Res. Treat. 2015, 347920 (2015).
-
(2015)
Stroke Res. Treat.
, vol.2015
, pp. 347920
-
-
Ponchel, A.1
Bombois, S.2
Bordet, R.3
Hénon, H.4
-
44
-
-
84929287206
-
Model of understanding fatigue after stroke
-
Wu, S., Mead, G., Macleod, M. & Chalder, T. Model of understanding fatigue after stroke. Stroke 46, 893-898 (2015).
-
(2015)
Stroke
, vol.46
, pp. 893-898
-
-
Wu, S.1
Mead, G.2
Macleod, M.3
Chalder, T.4
-
45
-
-
84880135284
-
Fatigue is associated with metabolic and density alterations of cortical and deep gray matter in relapsing-remitting-multiple sclerosis patients at the earlier stage of the disease: A PET/MR study
-
Derache, N. et al. Fatigue is associated with metabolic and density alterations of cortical and deep gray matter in relapsing-remitting-multiple sclerosis patients at the earlier stage of the disease: A PET/MR study. Mult. Scler. Relat. Disord. 2, 362-369 (2013).
-
(2013)
Mult. Scler. Relat. Disord.
, vol.2
, pp. 362-369
-
-
Derache, N.1
-
46
-
-
84926504978
-
The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders
-
Dobryakova, E., Genova, H. M., DeLuca, J. & Wylie, G. R. The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders. Front. Neurol. 6, 52 (2015).
-
(2015)
Front. Neurol.
, vol.6
, pp. 52
-
-
Dobryakova, E.1
Genova, H.M.2
DeLuca, J.3
Wylie, G.R.4
-
47
-
-
0024420189
-
The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus
-
Krupp, L. B., LaRocca, N. G., Muir-Nash, J. & Steinberg, A. D. The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch. Neurol. 46, 1121-1123 (1989).
-
(1989)
Arch. Neurol.
, vol.46
, pp. 1121-1123
-
-
Krupp, L.B.1
LaRocca, N.G.2
Muir-Nash, J.3
Steinberg, A.D.4
-
48
-
-
0034094589
-
Fatigue in multiple sclerosis and its relationship to depression and neurologic disability
-
Bakshi, R. et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult. Scler. 6, 181-185 (2000).
-
(2000)
Mult. Scler.
, vol.6
, pp. 181-185
-
-
Bakshi, R.1
-
49
-
-
18744380337
-
Fatigue in multiple sclerosis: A comparison of different rating scales and correlation to clinical parameters
-
Flachenecker, P. et al. Fatigue in multiple sclerosis: A comparison of different rating scales and correlation to clinical parameters. Mult. Scler. 8, 523-526 (2002).
-
(2002)
Mult. Scler.
, vol.8
, pp. 523-526
-
-
Flachenecker, P.1
-
50
-
-
84864041869
-
Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: A systematic review of measurement properties
-
Elbers, R. G. et al. Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: A systematic review of measurement properties. Qual. Life Res. 21, 925-944 (2012).
-
(2012)
Qual. Life Res.
, vol.21
, pp. 925-944
-
-
Elbers, R.G.1
-
51
-
-
0028214457
-
The impact of fatigue on patients with multiple sclerosis
-
Fisk, J. D., Pontefract, A., Ritvo, P. G., Archibald, C. J. & Murray, T. J. The impact of fatigue on patients with multiple sclerosis. Can. J. Neurol. Sci. 21, 9-14 (1994).
-
(1994)
Can. J. Neurol. Sci.
, vol.21
, pp. 9-14
-
-
Fisk, J.D.1
Pontefract, A.2
Ritvo, P.G.3
Archibald, C.J.4
Murray, T.J.5
-
52
-
-
15544386641
-
Does the modified fatigue impact scale offer a more comprehensive assessment of fatigue in MS
-
Téllez, N. et al. Does the modified fatigue impact scale offer a more comprehensive assessment of fatigue in MS Mult. Scler. 11, 198-202 (2005).
-
(2005)
Mult. Scler.
, vol.11
, pp. 198-202
-
-
Téllez, N.1
-
53
-
-
72749087539
-
The fatigue scale for motor and cognitive functions (FSMC): Validation of a new instrument to assess multiple sclerosis-related fatigue
-
Penner, I. K. et al. The fatigue scale for motor and cognitive functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult. Scler. 15, 1509-1517 (2009).
-
(2009)
Mult. Scler.
, vol.15
, pp. 1509-1517
-
-
Penner, I.K.1
-
54
-
-
84861218069
-
Assessment of post-stroke fatigue: The fatigue scale for motor and cognitive functions
-
Hubacher, M. et al. Assessment of post-stroke fatigue: The fatigue scale for motor and cognitive functions. Eur. Neurol. 67, 377-384 (2012).
-
(2012)
Eur. Neurol.
, vol.67
, pp. 377-384
-
-
Hubacher, M.1
-
55
-
-
84934343192
-
Increased TH17/TReg ratio in poststroke fatigue
-
Liu, X. et al. Increased TH17/TReg ratio in poststroke fatigue. Mediators Inflamm. 2015, 931398 (2015).
-
(2015)
Mediators Inflamm.
, vol.2015
, pp. 931398
-
-
Liu, X.1
-
57
-
-
0023939684
-
Fatigue in multiple sclerosis
-
Krupp, L. B., Alvarez, L. A., LaRocca, N. G. & Scheinberg, L. C. Fatigue in multiple sclerosis. Arch. Neurol. 45, 435-437 (1988).
-
(1988)
Arch. Neurol.
, vol.45
, pp. 435-437
-
-
Krupp, L.B.1
Alvarez, L.A.2
LaRocca, N.G.3
Scheinberg, L.C.4
-
58
-
-
0028822583
-
Fatigue in MS is associated with specific clinical features
-
Colosimo, C. et al. Fatigue in MS is associated with specific clinical features. Acta Neurol. Scand. 92, 353-355 (1995).
-
(1995)
Acta Neurol. Scand.
, vol.92
, pp. 353-355
-
-
Colosimo, C.1
-
59
-
-
0035077361
-
Physiopathology and treatment of fatigue in multiple sclerosis
-
Comi, G., Leocani, L., Rossi, P. & Colombo, B. Physiopathology and treatment of fatigue in multiple sclerosis. J. Neurol. 248, 174-179 (2001).
-
(2001)
J. Neurol.
, vol.248
, pp. 174-179
-
-
Comi, G.1
Leocani, L.2
Rossi, P.3
Colombo, B.4
-
60
-
-
0034750269
-
Quality of life in multiple sclerosis: The impact of depression, fatigue and disability
-
Amato, M. P. et al. Quality of life in multiple sclerosis: The impact of depression, fatigue and disability. Mult. Scler. 7, 340-344 (2001).
-
(2001)
Mult. Scler.
, vol.7
, pp. 340-344
-
-
Amato, M.P.1
-
61
-
-
84874940265
-
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: A cross-sectional study
-
Flensner, G., Landtblom, A. M., Söderhamn, O. & Ek, A. C. Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: A cross-sectional study. BMC Public Health 13, 224 (2013).
-
(2013)
BMC Public Health
, vol.13
, pp. 224
-
-
Flensner, G.1
Landtblom, A.M.2
Söderhamn, O.3
Ek, A.C.4
-
63
-
-
80053451412
-
The relationship between fatigue and other clinical features of multiple sclerosis
-
Mills, R. J. & Young, C. A. The relationship between fatigue and other clinical features of multiple sclerosis. Mult. Scler. 17, 604-612 (2011).
-
(2011)
Mult. Scler.
, vol.17
, pp. 604-612
-
-
Mills, R.J.1
Young, C.A.2
-
64
-
-
84856722766
-
Fatigue in multiple sclerosis: Which patient should be referred to a sleep specialist
-
Veauthier, C. & Paul, F. Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist Mult. Scler. 18, 248-249 (2012).
-
(2012)
Mult. Scler.
, vol.18
, pp. 248-249
-
-
Veauthier, C.1
Paul, F.2
-
65
-
-
84891628450
-
Sleep disorders in multiple sclerosis and their relationship to fatigue
-
Veauthier, C. & Paul, F. Sleep disorders in multiple sclerosis and their relationship to fatigue. Sleep Med. 15, 5-14 (2014).
-
(2014)
Sleep Med.
, vol.15
, pp. 5-14
-
-
Veauthier, C.1
Paul, F.2
-
66
-
-
84979223208
-
Therapy of fatigue in multiple sclerosis: A treatment algorithm [German]
-
Veauthier, C. & Paul, F. Therapy of fatigue in multiple sclerosis: A treatment algorithm [German]. Nervenarzt 87, 1310-1321 (2016).
-
(2016)
Nervenarzt
, vol.87
, pp. 1310-1321
-
-
Veauthier, C.1
Paul, F.2
-
67
-
-
84941901406
-
Pharmacological treatments for fatigue associated with palliative care
-
Mücke, M. et al. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst. Rev. 5, CD006788 (2015).
-
(2015)
Cochrane Database Syst. Rev.
, vol.5
, pp. CD006788
-
-
Mücke, M.1
-
68
-
-
84907944162
-
Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: Exercise, education, and medication
-
Asano, M. & Finlayson, M. L. Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication. Mult. Scler. Int. 2014, 798285 (2014).
-
(2014)
Mult. Scler. Int.
, vol.2014
, pp. 798285
-
-
Asano, M.1
Finlayson, M.L.2
-
69
-
-
79952110038
-
Pharmacological treatments for fatigue associated with palliative care
-
Peuckmann, V., Elsner, F., Krumm, N., Trottenberg, P. & Radbruch, L. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst. Rev. 11, CD006788 (2010).
-
(2010)
Cochrane Database Syst. Rev.
, vol.11
, pp. CD006788
-
-
Peuckmann, V.1
Elsner, F.2
Krumm, N.3
Trottenberg, P.4
Radbruch, L.5
-
70
-
-
84963751173
-
Fatigue management in multiple sclerosis
-
Tur, C. Fatigue management in multiple sclerosis. Curr. Treat. Options Neurol. 18, 26 (2016).
-
(2016)
Curr. Treat. Options Neurol.
, vol.18
, pp. 26
-
-
Tur, C.1
-
71
-
-
84984833776
-
Fatigue and depression in multiple sclerosis: Pharmacological and non-pharmacological interventions
-
Brenner, P. & Piehl, F. Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions. Acta Neurol. Scand. 134, 47-54 (2016).
-
(2016)
Acta Neurol. Scand.
, vol.134
, pp. 47-54
-
-
Brenner, P.1
Piehl, F.2
-
72
-
-
0023231728
-
A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis
-
Hader, W. et al. A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. Can. J. Neurol. Sci. 14, 273-278 (1987).
-
(1987)
Can. J. Neurol. Sci.
, vol.14
, pp. 273-278
-
-
Hader, W.1
-
73
-
-
0024340480
-
Amantadine treatment of fatigue associated with multiple sclerosis
-
Cohen, R. A. & Fisher, M. Amantadine treatment of fatigue associated with multiple sclerosis. Arch. Neurol. 46, 676-680 (1989).
-
(1989)
Arch. Neurol.
, vol.46
, pp. 676-680
-
-
Cohen, R.A.1
Fisher, M.2
-
74
-
-
84890054444
-
Evaluating the effects of amantadin, modafinil and acetyl-l carnitine on fatigue in multiple sclerosis -result of a pilot randomized, blind study
-
Ledinek, A. H., Sajko, M. C. & Rot, U. Evaluating the effects of amantadin, modafinil and acetyl-l carnitine on fatigue in multiple sclerosis -result of a pilot randomized, blind study. Clin. Neurol. Neurosurg. 115 (Suppl. 1), S86-S89 (2013).
-
(2013)
Clin. Neurol. Neurosurg.
, vol.115
, pp. S86-S89
-
-
Ledinek, A.H.1
Sajko, M.C.2
Rot, U.3
-
75
-
-
0030019643
-
The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis
-
Geisler, M. W. et al. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis. Arch. Neurol. 53, 185-188 (1996).
-
(1996)
Arch. Neurol.
, vol.53
, pp. 185-188
-
-
Geisler, M.W.1
-
76
-
-
0029400839
-
Fatigue therapy in multiple sclerosis: Results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo
-
Krupp, L. B. et al. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 45, 1956-1961 (1995).
-
(1995)
Neurology
, vol.45
, pp. 1956-1961
-
-
Krupp, L.B.1
-
77
-
-
0022257683
-
Amantadine therapy for fatigue in multiple sclerosis
-
Murray, T. J. Amantadine therapy for fatigue in multiple sclerosis. Can. J. Neurol. Sci. 12, 251-254 (1985).
-
(1985)
Can. J. Neurol. Sci.
, vol.12
, pp. 251-254
-
-
Murray, T.J.1
-
78
-
-
0023773366
-
Amantadine, fatigue, and multiple sclerosis
-
Rosenberg, G. A. & Appenzeller, O. Amantadine, fatigue, and multiple sclerosis. Arch. Neurol. 45, 1104-1106 (1988).
-
(1988)
Arch. Neurol.
, vol.45
, pp. 1104-1106
-
-
Rosenberg, G.A.1
Appenzeller, O.2
-
79
-
-
70449642846
-
Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis
-
Ashtari, F., Fatehi, F., Shaygannejad, V. & Chitsaz, A. Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis Neurol. Neurochir. Pol. 43, 428-432 (2009).
-
(2009)
Neurol Neurochir Pol.
, vol.43
, pp. 428-432
-
-
Ashtari, F.1
Fatehi, F.2
Shaygannejad, V.3
Chitsaz, A.4
-
80
-
-
84867915848
-
Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: A randomized, blinded, crossover study
-
Shaygannejad, V., Janghorbani, M., Ashtari, F. & Zakeri, H. Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: A randomized, blinded, crossover study. Neurol. Res. 34, 854-858 (2012).
-
(2012)
Neurol. Res.
, vol.34
, pp. 854-858
-
-
Shaygannejad, V.1
Janghorbani, M.2
Ashtari, F.3
Zakeri, H.4
-
81
-
-
37049017697
-
Amantadine for fatigue in multiple sclerosis
-
Pucci, E. et al. Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst. Rev. 1, CD002818 (2007).
-
(2007)
Cochrane Database Syst. Rev.
, vol.1
, pp. CD002818
-
-
Pucci, E.1
-
82
-
-
18744371810
-
Amantadine for fatigue in multiple sclerosis
-
Taus, C., Giuliani, G., Pucci, E., D'Amico, R. & Solari, A. Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst. Rev. 2, CD002818 (2003).
-
(2003)
Cochrane Database Syst. Rev.
, vol.2
, pp. CD002818
-
-
Taus, C.1
Giuliani, G.2
Pucci, E.3
D'Amico, R.4
Solari, A.5
-
83
-
-
52449091605
-
Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis
-
Ziemssen, T., Hoffman, J., Apfel, R. & Kern, S. Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis. Health Qual. Life Outcomes 6, 67 (2008).
-
(2008)
Health Qual. Life Outcomes
, vol.6
, pp. 67
-
-
Ziemssen, T.1
Hoffman, J.2
Apfel, R.3
Kern, S.4
-
84
-
-
69549130717
-
Multiple sclerosis associated fatigue during natalizumab treatment
-
Putzki, N., Yaldizli, Ö., Tettenborn, B. & Diener, H. C. Multiple sclerosis associated fatigue during natalizumab treatment. J. Neurol. Sci. 285, 109-113 (2009).
-
(2009)
J. Neurol. Sci.
, vol.285
, pp. 109-113
-
-
Putzki, N.1
Yaldizli, Ö.2
Tettenborn, B.3
Diener, H.C.4
-
85
-
-
79953185078
-
Multiple sclerosis-associated fatigue during disease-modifying treatment with natalizumab, interferon and glatiramer acetate
-
Yildiz, M., Tettenborn, B. & Putzki, N. Multiple sclerosis-associated fatigue during disease-modifying treatment with natalizumab, interferon and glatiramer acetate. Eur. Neurol. 65, 231-232 (2011).
-
(2011)
Eur. Neurol.
, vol.65
, pp. 231-232
-
-
Yildiz, M.1
Tettenborn, B.2
Putzki, N.3
-
86
-
-
84866177950
-
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: A prospective, open-label, two years observational study
-
Iaffaldano, P. et al. Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: A prospective, open-label, two years observational study. PLoS ONE 7, e35843 (2012).
-
(2012)
PLoS ONE
, vol.7
, pp. e35843
-
-
Iaffaldano, P.1
-
87
-
-
84875281260
-
Natalizumab treatment reduces fatigue in multiple sclerosis Results from the TYNERGY trial; A study in the real life setting
-
Svenningsson, A. et al. Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting. PLoS ONE 8, e58643 (2013).
-
(2013)
PLoS ONE
, vol.8
, pp. e58643
-
-
Svenningsson, A.1
-
88
-
-
84894271594
-
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): A randomised, double-blind, placebo-controlled, phase 3 trial
-
Confavreux, C. et al. Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): A randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 13, 247-256 (2014).
-
(2014)
Lancet Neurol.
, vol.13
, pp. 247-256
-
-
Confavreux, C.1
-
89
-
-
84897022266
-
Teriflunomide versus subcutaneous interferon 1a in patients with relapsing multiple sclerosis: A randomised, controlled phase 3 trial
-
Vermersch, P. et al. Teriflunomide versus subcutaneous interferon 1a in patients with relapsing multiple sclerosis: A randomised, controlled phase 3 trial. Mult. Scler. 20, 705-716 (2014).
-
(2014)
Mult. Scler.
, vol.20
, pp. 705-716
-
-
Vermersch, P.1
-
90
-
-
79951946144
-
Sensitivity to heat in MS patients: A factor strongly influencing symptomology -an explorative survey
-
Flensner, G., Ek, A. C., Söderhamn, O. & Landtblom, A. M. Sensitivity to heat in MS patients: A factor strongly influencing symptomology -an explorative survey. BMC Neurol. 11, 27 (2011).
-
(2011)
BMC Neurol.
, vol.11
, pp. 27
-
-
Flensner, G.1
Ek, A.C.2
Söderhamn, O.3
Landtblom, A.M.4
-
91
-
-
0038714573
-
A randomized controlled study of the acute and chronic effects of cooling therapy for MS
-
Schwid, S. R. et al. A randomized controlled study of the acute and chronic effects of cooling therapy for MS. Neurology 60, 1955-1960 (2003).
-
(2003)
Neurology
, vol.60
, pp. 1955-1960
-
-
Schwid, S.R.1
-
92
-
-
84955079530
-
Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A case-control study
-
Miller, E., Kostka, J., Wodarczyk, T. & Dugué, B. Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A case-control study. Acta Neurol. Scand. 134, 420-426 (2016).
-
(2016)
Acta Neurol. Scand.
, vol.134
, pp. 420-426
-
-
Miller, E.1
Kostka, J.2
Wodarczyk, T.3
Dugué, B.4
-
93
-
-
21644452131
-
Relaxation and health-related quality of life in multiple sclerosis: The example of autogenic training
-
Sutherland, G., Andersen, M. B. & Morris, T. Relaxation and health-related quality of life in multiple sclerosis: The example of autogenic training. J. Behav. Med. 28, 249-256 (2005).
-
(2005)
J. Behav. Med.
, vol.28
, pp. 249-256
-
-
Sutherland, G.1
Andersen, M.B.2
Morris, T.3
-
94
-
-
84867538376
-
Evaluation of the effect of progressive relaxation exercises on fatigue and sleep quality in patients with multiple sclerosis
-
Dayapolu, N. & Tan, M. Evaluation of the effect of progressive relaxation exercises on fatigue and sleep quality in patients with multiple sclerosis. J. Altern. Complement. Med. 18, 983-987 (2012).
-
(2012)
J. Altern. Complement. Med.
, vol.18
, pp. 983-987
-
-
Dayapolu, N.1
Tan, M.2
-
95
-
-
84983371734
-
The self-directed biological transformation initiative and well-being
-
Mills, P. J. et al. The self-directed biological transformation initiative and well-being. J. Altern. Complement. Med. 22, 627-634 (2016).
-
(2016)
J. Altern. Complement. Med.
, vol.22
, pp. 627-634
-
-
Mills, P.J.1
-
96
-
-
2942538466
-
Randomized controlled trial of yoga and exercise in multiple sclerosis
-
Oken, B. S. et al. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology 62, 2058-2064 (2004).
-
(2004)
Neurology
, vol.62
, pp. 2058-2064
-
-
Oken, B.S.1
-
97
-
-
77955658183
-
Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis
-
Velikonja, O., uric, K., Ožura, A. & Jazbec, S. Š. Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clin. Neurol. Neurosurg. 112, 597-601 (2010).
-
(2010)
Clin. Neurol. Neurosurg.
, vol.112
, pp. 597-601
-
-
Velikonja, O.1
Uric, K.2
Ožura, A.3
Jazbec, S.Š.4
-
98
-
-
84949845279
-
Exercising impacts on fatigue, depression, and paresthesia in female patients with multiple sclerosis
-
Razazian, N. et al. Exercising impacts on fatigue, depression, and paresthesia in female patients with multiple sclerosis. Med. Sci. Sports Exerc. 48, 796-803 (2016).
-
(2016)
Med. Sci. Sports Exerc.
, vol.48
, pp. 796-803
-
-
Razazian, N.1
-
99
-
-
84860390114
-
The effect of exercise therapy on fatigue in multiple sclerosis
-
Andreasen, A. K., Stenager, E. & Dalgas, U. The effect of exercise therapy on fatigue in multiple sclerosis. Mult. Scler. 17, 1041-1054 (2011).
-
(2011)
Mult. Scler.
, vol.17
, pp. 1041-1054
-
-
Andreasen, A.K.1
Stenager, E.2
Dalgas, U.3
-
100
-
-
0036200218
-
Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis
-
Mostert, S. & Kesselring, J. Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult. Scler. 8, 161-168 (2002).
-
(2002)
Mult. Scler.
, vol.8
, pp. 161-168
-
-
Mostert, S.1
Kesselring, J.2
-
101
-
-
70349771199
-
Comparing individualized rehabilitation to a group wellness intervention for persons with multiple sclerosis
-
Plow, M. A., Mathiowetz, V. & Lowe, D. A. Comparing individualized rehabilitation to a group wellness intervention for persons with multiple sclerosis. Am. J. Health Promot. 24, 23-26 (2009).
-
(2009)
Am. J. Health Promot.
, vol.24
, pp. 23-26
-
-
Plow, M.A.1
Mathiowetz, V.2
Lowe, D.A.3
-
102
-
-
41549125860
-
Long-term benefits of exercising on quality of life and fatigue in multiple sclerosis patients with mild disability: A pilot study
-
McCullagh, R., Fitzgerald, A. P., Murphy, R. P. & Cooke, G. Long-term benefits of exercising on quality of life and fatigue in multiple sclerosis patients with mild disability: A pilot study. Clin. Rehabil. 22, 206-214 (2008).
-
(2008)
Clin. Rehabil.
, vol.22
, pp. 206-214
-
-
McCullagh, R.1
Fitzgerald, A.P.2
Murphy, R.P.3
Cooke, G.4
-
103
-
-
77954661488
-
Fatigue, mood and quality of life improve in MS patients after progressive resistance training
-
Dalgas, U. et al. Fatigue, mood and quality of life improve in MS patients after progressive resistance training. Mult. Scler. 16, 480-490 (2010).
-
(2010)
Mult. Scler.
, vol.16
, pp. 480-490
-
-
Dalgas, U.1
-
104
-
-
84866368728
-
Effect of aquatic exercise training on fatigue and health-related quality of life in patients with multiple sclerosis
-
Kargarfard, M., Etemadifar, M., Baker, P., Mehrabi, M. & Hayatbakhsh, R. Effect of aquatic exercise training on fatigue and health-related quality of life in patients with multiple sclerosis. Arch. Phys. Med. Rehabil. 93, 1701-1708 (2012).
-
(2012)
Arch. Phys. Med. Rehabil.
, vol.93
, pp. 1701-1708
-
-
Kargarfard, M.1
Etemadifar, M.2
Baker, P.3
Mehrabi, M.4
Hayatbakhsh, R.5
-
105
-
-
84876546570
-
Training in MS: Influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial
-
Bansi, J., Bloch, W., Gamper, U. & Kesselring, J. Training in MS: influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial. Mult. Scler. 19, 613-621 (2012).
-
(2012)
Mult. Scler.
, vol.19
, pp. 613-621
-
-
Bansi, J.1
Bloch, W.2
Gamper, U.3
Kesselring, J.4
-
106
-
-
84959439564
-
Exercise therapy for fatigue in multiple sclerosis
-
Heine, M., van de Port, I., Rietberg, M. B., van Wegen, E. E. & Kwakkel, G. Exercise therapy for fatigue in multiple sclerosis. Cochrane Database Syst Rev. 9, CD009956 (2015).
-
(2015)
Cochrane Database Syst Rev.
, vol.9
, pp. CD009956
-
-
Heine, M.1
Van De Port, I.2
Rietberg, M.B.3
Van Wegen, E.E.4
Kwakkel, G.5
-
107
-
-
39149138967
-
A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue
-
van Kessel, K. et al. A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue. Psychosom. Med. 70, 205-213 (2008).
-
(2008)
Psychosom. Med.
, vol.70
, pp. 205-213
-
-
Van Kessel, K.1
-
108
-
-
85032458719
-
Online fatigue management program for patients with multiple sclerosis -a randomized controlled trial
-
Poettgen, J. et al. Online fatigue management program for patients with multiple sclerosis -a randomized controlled trial. Mult. Scler. 21, 41-42 (2015).
-
(2015)
Mult. Scler.
, vol.21
, pp. 41-42
-
-
Poettgen, J.1
-
109
-
-
84877276124
-
Treatment of fatigue in multiple sclerosis patients: A neurocognitive approach
-
Catalan, M. et al. Treatment of fatigue in multiple sclerosis patients: A neurocognitive approach. Rehabil. Res. Pract. 2011, 670537 (2011).
-
(2011)
Rehabil. Res. Pract.
, vol.2011
, pp. 670537
-
-
Catalan, M.1
-
110
-
-
77957946229
-
MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial
-
Grossman, P. et al. MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial. Neurology 75, 1141-1149 (2010).
-
(2010)
Neurology
, vol.75
, pp. 1141-1149
-
-
Grossman, P.1
-
112
-
-
68149164576
-
Working memory training in patients with multiple sclerosis -comparison of two different training schedules
-
Vogt, A. et al. Working memory training in patients with multiple sclerosis -comparison of two different training schedules. Restor. Neurol. Neurosci. 27, 225-235 (2009).
-
(2009)
Restor. Neurol. Neurosci.
, vol.27
, pp. 225-235
-
-
Vogt, A.1
-
113
-
-
84975317311
-
Inflammation and the silent sequelae of stroke
-
Becker, K. J. Inflammation and the silent sequelae of stroke. Neurotherapeutics 13, 801-810 (2016).
-
(2016)
Neurotherapeutics
, vol.13
, pp. 801-810
-
-
Becker, K.J.1
-
114
-
-
84898410620
-
Neuropsychiatric outcomes of stroke
-
Hackett, M. L., Köhler, S., O'Brien, J. T. & Mead, G. E. Neuropsychiatric outcomes of stroke. Lancet Neurol. 13, 525-534 (2014).
-
(2014)
Lancet Neurol.
, vol.13
, pp. 525-534
-
-
Hackett, M.L.1
Köhler, S.2
O'Brien, J.T.3
Mead, G.E.4
-
115
-
-
0035174605
-
Experience of severe fatigue long after stroke and its relation to depressive symptoms and disease characteristics
-
van der Werf, S. P., van den Broek, H. L., Anten, H. W. & Bleijenberg, G. Experience of severe fatigue long after stroke and its relation to depressive symptoms and disease characteristics. Eur. Neurol. 45, 28-33 (2001).
-
(2001)
Eur. Neurol.
, vol.45
, pp. 28-33
-
-
Van Der Werf, S.P.1
Van Den Broek, H.L.2
Anten, H.W.3
Bleijenberg, G.4
-
116
-
-
33846921811
-
Fluoxetine is not effective in the treatment of post-stroke fatigue: A double-blind, placebo-controlled study
-
Choi-Kwon, S., Choi, J., Kwon, S. U., Kang, D. W. & Kim, J. S. Fluoxetine is not effective in the treatment of post-stroke fatigue: A double-blind, placebo-controlled study. Cerebrovasc. Dis. 23, 103-108 (2007).
-
(2007)
Cerebrovasc. Dis.
, vol.23
, pp. 103-108
-
-
Choi-Kwon, S.1
Choi, J.2
Kwon, S.U.3
Kang, D.W.4
Kim, J.S.5
-
117
-
-
35548964718
-
Fatigue after stroke: The development and evaluation of a case definition
-
Lynch, J. et al. Fatigue after stroke: The development and evaluation of a case definition. J. Psychosom. Res. 63, 539-544 (2007).
-
(2007)
J. Psychosom. Res.
, vol.63
, pp. 539-544
-
-
Lynch, J.1
-
118
-
-
84862214149
-
Frequency and natural history of fatigue after stroke: A systematic review of longitudinal studies
-
Duncan, F., Wu, S. & Mead, G. E. Frequency and natural history of fatigue after stroke: A systematic review of longitudinal studies. J. Psychosom. Res. 73, 18-27 (2012).
-
(2012)
J. Psychosom. Res.
, vol.73
, pp. 18-27
-
-
Duncan, F.1
Wu, S.2
Mead, G.E.3
-
119
-
-
84858289910
-
Post-stroke fatigue and return to work: A 2 year follow up
-
Andersen, G., Christensen, D., Kirkevold, M. & Johnsen, S. P. Post-stroke fatigue and return to work: A 2 year follow up. Acta Neurol. Scand. 125, 248-253 (2012).
-
(2012)
Acta Neurol. Scand.
, vol.125
, pp. 248-253
-
-
Andersen, G.1
Christensen, D.2
Kirkevold, M.3
Johnsen, S.P.4
-
120
-
-
77949262388
-
Acute basal ganglia infarcts in poststroke fatigue: An MRI study
-
Tang, W. K. et al. Acute basal ganglia infarcts in poststroke fatigue: An MRI study. J. Neurol. 257, 178-182 (2010).
-
(2010)
J. Neurol.
, vol.257
, pp. 178-182
-
-
Tang, W.K.1
-
121
-
-
84870896940
-
Poststroke fatigue is associated with caudate infarcts
-
Tang, W. K. et al. Poststroke fatigue is associated with caudate infarcts. J. Neurol. Sci. 324, 131-135 (2013).
-
(2013)
J. Neurol. Sci.
, vol.324
, pp. 131-135
-
-
Tang, W.K.1
-
122
-
-
14044255786
-
Poststroke fatigue: Characteristics and related factors
-
Choi-Kwon, S., Han, S. W., Kwon, S. U. & Kim, J. S. Poststroke fatigue: characteristics and related factors. Cerebrovasc. Dis. 19, 84-90 (2005).
-
(2005)
Cerebrovasc. Dis.
, vol.19
, pp. 84-90
-
-
Choi-Kwon, S.1
Han, S.W.2
Kwon, S.U.3
Kim, J.S.4
-
123
-
-
49949118538
-
Dimensions of post-stroke fatigue: A two-year follow up study
-
Christensen, D. et al. Dimensions of post-stroke fatigue: A two-year follow up study. Cerebrovasc. Dis. 26, 134-141 (2008).
-
(2008)
Cerebrovasc. Dis.
, vol.26
, pp. 134-141
-
-
Christensen, D.1
-
124
-
-
84990239374
-
Self-reported fatigue and associated factors six years after stroke
-
Elf, M., Eriksson, G., Johansson, S., von Koch, L. & Ytterberg, C. Self-reported fatigue and associated factors six years after stroke. PLoS ONE 11, e0161942 (2016).
-
(2016)
PLoS ONE
, vol.11
, pp. e0161942
-
-
Elf, M.1
Eriksson, G.2
Johansson, S.3
Von Koch, L.4
Ytterberg, C.5
-
125
-
-
68349085674
-
Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients
-
Brioschi, A. et al. Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. Eur. Neurol. 62, 243-249 (2009).
-
(2009)
Eur. Neurol.
, vol.62
, pp. 243-249
-
-
Brioschi, A.1
-
126
-
-
84948067409
-
Modafinil may alleviate poststroke fatigue: A randomized, placebo-controlled, double-blinded trial
-
Poulsen, M. B., Damgaard, B., Zerahn, B., Overgaard, K. & Rasmussen, R. S. Modafinil may alleviate poststroke fatigue: A randomized, placebo-controlled, double-blinded trial. Stroke 46, 3470-3477 (2015).
-
(2015)
Stroke
, vol.46
, pp. 3470-3477
-
-
Poulsen, M.B.1
Damgaard, B.2
Zerahn, B.3
Overgaard, K.4
Rasmussen, R.S.5
-
127
-
-
84982206005
-
Modafinil in Debilitating fatigue after Stroke (MIDAS): Study protocol for a randomised, double-blinded, placebo-controlled, crossover trial
-
Lillicrap, T. et al. Modafinil In Debilitating fatigue After Stroke (MIDAS): study protocol for a randomised, double-blinded, placebo-controlled, crossover trial. Trials 17, 410 (2016).
-
(2016)
Trials
, vol.17
, pp. 410
-
-
Lillicrap, T.1
-
128
-
-
85017440286
-
MIDAS (Modafinil in Debilitating Fatigue after Stroke): A randomized, double-blind, placebo-controlled, cross-over trial
-
Bivard, A. et al. MIDAS (Modafinil in Debilitating Fatigue After Stroke): A randomized, double-blind, placebo-controlled, cross-over trial. Stroke 48, 1293-1298 (2017).
-
(2017)
Stroke
, vol.48
, pp. 1293-1298
-
-
Bivard, A.1
-
129
-
-
84867550690
-
Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue
-
Karaiskos, D., Tzavellas, E., Spengos, K., Vassilopoulou, S. & Paparrigopoulos, T. Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue. J. Neuropsychiatry Clin. Neurosci. 24, 349-353 (2012).
-
(2012)
J. Neuropsychiatry Clin. Neurosci.
, vol.24
, pp. 349-353
-
-
Karaiskos, D.1
Tzavellas, E.2
Spengos, K.3
Vassilopoulou, S.4
Paparrigopoulos, T.5
-
130
-
-
84990052930
-
Post-stroke mood and emotional disturbances: Pharmacological therapy based on mechanisms
-
Kim, J. S. Post-stroke mood and emotional disturbances: pharmacological therapy based on mechanisms. J. Stroke 18, 244-255 (2016).
-
(2016)
J. Stroke
, vol.18
, pp. 244-255
-
-
Kim, J.S.1
-
131
-
-
84858849503
-
Poststroke fatigue: Does group education make a difference A randomized pilot trial
-
Clarke, A., Barker-Collo, S. L. & Feigin, V. L. Poststroke fatigue: does group education make a difference A randomized pilot trial. Top. Stroke Rehabil. 19, 32-39 (2012).
-
(2012)
Top. Stroke Rehabil.
, vol.19
, pp. 32-39
-
-
Clarke, A.1
Barker-Collo, S.L.2
Feigin, V.L.3
-
132
-
-
84859310283
-
Cognitive and graded activity training can alleviate persistent fatigue after stroke: A randomized, controlled trial
-
Zedlitz, A. M., Rietveld, T. C., Geurts, A. C. & Fasotti, L. Cognitive and graded activity training can alleviate persistent fatigue after stroke: A randomized, controlled trial. Stroke J. 43, 1046-1051 (2012).
-
(2012)
Stroke J.
, vol.43
, pp. 1046-1051
-
-
Zedlitz, A.M.1
Rietveld, T.C.2
Geurts, A.C.3
Fasotti, L.4
-
133
-
-
84869477451
-
Mindfulness-based stress reduction (MBSR) improves long-term mental fatigue after stroke or traumatic brain injury
-
Johansson, B., Bjuhr, H. & Rönnbäck, L. Mindfulness-based stress reduction (MBSR) improves long-term mental fatigue after stroke or traumatic brain injury. Brain Inj. 26, 1621-1628 (2012).
-
(2012)
Brain Inj.
, vol.26
, pp. 1621-1628
-
-
Johansson, B.1
Bjuhr, H.2
Rönnbäck, L.3
-
134
-
-
8844235607
-
Is fatigue an independent and persistent symptom in patients with Parkinson disease
-
Alves, G., Wentzel-Larsen, T. & Larsen, J. P. Is fatigue an independent and persistent symptom in patients with Parkinson disease Neurology 63, 1908-1911 (2004).
-
(2004)
Neurology
, vol.63
, pp. 1908-1911
-
-
Alves, G.1
Wentzel-Larsen, T.2
Larsen, J.P.3
-
135
-
-
0036836047
-
Measuring fatigue in patients with Parkinson's disease -the fatigue severity scale
-
Herlofson, K. & Larsen, J. P. Measuring fatigue in patients with Parkinson's disease -the fatigue severity scale. Eur. J. Neurol. 9, 595-600 (2002).
-
(2002)
Eur. J. Neurol.
, vol.9
, pp. 595-600
-
-
Herlofson, K.1
Larsen, J.P.2
-
136
-
-
41849086277
-
Impact of fatigue on quality of life in patients with Parkinson's disease
-
Havlikova, E. et al. Impact of fatigue on quality of life in patients with Parkinson's disease. Eur. J. Neurol. 15, 475-480 (2008).
-
(2008)
Eur. J. Neurol.
, vol.15
, pp. 475-480
-
-
Havlikova, E.1
-
137
-
-
77951960974
-
Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease
-
Friedman, J. H. et al. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov. Disord. 25, 805-822 (2010).
-
(2010)
Mov. Disord.
, vol.25
, pp. 805-822
-
-
Friedman, J.H.1
-
138
-
-
84973344711
-
Interventions for fatigue in Parkinson's disease
-
Elbers, R. G., Verhoef, J., van Wegen, E. E., Berendse, H. W. & Kwakkel, G. Interventions for fatigue in Parkinson's disease. Cochrane Database Syst Rev. 10, CD010925 (2015).
-
(2015)
Cochrane Database Syst Rev.
, vol.10
, pp. CD010925
-
-
Elbers, R.G.1
Verhoef, J.2
Van Wegen, E.E.3
Berendse, H.W.4
Kwakkel, G.5
-
139
-
-
84973295214
-
Treatment of fatigue in Parkinson disease
-
Elbers, R. G., Berendse, H. W. & Kwakkel, G. Treatment of fatigue in Parkinson disease. JAMA 315, 2340-2341 (2016).
-
(2016)
JAMA
, vol.315
, pp. 2340-2341
-
-
Elbers, R.G.1
Berendse, H.W.2
Kwakkel, G.3
-
140
-
-
77952818833
-
Central and peripheral fatigue: Exemplified by multiple sclerosis and myasthenia gravis
-
Cantor, F. Central and peripheral fatigue: exemplified by multiple sclerosis and myasthenia gravis. PM R. 2, 399-405 (2010).
-
(2010)
PM R.
, vol.2
, pp. 399-405
-
-
Cantor, F.1
-
141
-
-
84986586574
-
Muscle strength and fatigue in newly diagnosed patients with myasthenia gravis
-
Vinge, L. & Andersen, H. Muscle strength and fatigue in newly diagnosed patients with myasthenia gravis. Muscle Nerve 54, 709-714 (2016).
-
(2016)
Muscle Nerve
, vol.54
, pp. 709-714
-
-
Vinge, L.1
Andersen, H.2
-
142
-
-
84953837822
-
Quantitative motor assessment of muscular weakness in myasthenia gravis: A pilot study
-
Hoffmann, S. et al. Quantitative motor assessment of muscular weakness in myasthenia gravis: A pilot study. BMC Neurol. 15, 265 (2015).
-
(2015)
BMC Neurol.
, vol.15
, pp. 265
-
-
Hoffmann, S.1
-
143
-
-
84980368667
-
International consensus guidance for management of myasthenia gravis: Executive summary
-
Sanders, D. B. et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology 87, 419-425 (2016).
-
(2016)
Neurology
, vol.87
, pp. 419-425
-
-
Sanders, D.B.1
-
144
-
-
0033812353
-
Fatigue and its impact on patients with myasthenia gravis
-
Paul, R. H., Cohen, R. A., Goldstein, J. M. & Gilchrist, J. M. Fatigue and its impact on patients with myasthenia gravis. Muscle Nerve 23, 1402-1406 (2000).
-
(2000)
Muscle Nerve
, vol.23
, pp. 1402-1406
-
-
Paul, R.H.1
Cohen, R.A.2
Goldstein, J.M.3
Gilchrist, J.M.4
-
145
-
-
77649096679
-
Muscle strength and fatigue in patients with generalized myasthenia gravis
-
Symonette, C. J., Watson, B. V., Koopman, W. J., Nicolle, M. W. & Doherty, T. J. Muscle strength and fatigue in patients with generalized myasthenia gravis. Muscle Nerve 41, 362-369 (2010).
-
(2010)
Muscle Nerve
, vol.41
, pp. 362-369
-
-
Symonette, C.J.1
Watson, B.V.2
Koopman, W.J.3
Nicolle, M.W.4
Doherty, T.J.5
-
146
-
-
84884886539
-
Fatigue in myasthenia gravis: Is it more than muscular weakness
-
Elsais, A., Wyller, V. B., Loge, J. H. & Kerty, E. Fatigue in myasthenia gravis: is it more than muscular weakness BMC Neurol. 13, 132 (2013).
-
(2013)
BMC Neurol.
, vol.13
, pp. 132
-
-
Elsais, A.1
Wyller, V.B.2
Loge, J.H.3
Kerty, E.4
-
147
-
-
0033016944
-
The autonomic symptom profile: A new instrument to assess autonomic symptoms
-
Suarez, G. A. et al. The autonomic symptom profile: A new instrument to assess autonomic symptoms. Neurology 52, 523-528 (1999).
-
(1999)
Neurology
, vol.52
, pp. 523-528
-
-
Suarez, G.A.1
-
148
-
-
84869490487
-
Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: A pilot study
-
Askmark, H., Haggrd, L., Nygren, I. & Punga, A. R. Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: A pilot study. Eur. J. Neurol. 19, 1554-1560 (2012).
-
(2012)
Eur. J. Neurol.
, vol.19
, pp. 1554-1560
-
-
Askmark, H.1
Haggrd, L.2
Nygren, I.3
Punga, A.R.4
-
149
-
-
84870039138
-
Fatigue in motor neuron diseases
-
Abraham, A. & Drory, V. E. Fatigue in motor neuron diseases. Neuromuscul. Disord. 22 (Suppl. 3), S198-S202 (2012).
-
(2012)
Neuromuscul. Disord.
, vol.22
, pp. S198-S202
-
-
Abraham, A.1
Drory, V.E.2
-
150
-
-
42549162068
-
Fatigue in amyotrophic lateral sclerosis: Frequency and associated factors
-
Ramirez, C., Piemonte, M. E., Callegaro, D. & Da Silva, H. C. Fatigue in amyotrophic lateral sclerosis: frequency and associated factors. Amyotroph. Lateral Scler. 9, 75-80 (2008).
-
(2008)
Amyotroph. Lateral Scler.
, vol.9
, pp. 75-80
-
-
Ramirez, C.1
Piemonte, M.E.2
Callegaro, D.3
Da Silva, H.C.4
-
151
-
-
0037435527
-
Fatigue and depression are associated with poor quality of life in ALS
-
Lou, J. S., Reeves, A., Benice, T. & Sexton, G. Fatigue and depression are associated with poor quality of life in ALS. Neurology 60, 122-123 (2003).
-
(2003)
Neurology
, vol.60
, pp. 122-123
-
-
Lou, J.S.1
Reeves, A.2
Benice, T.3
Sexton, G.4
-
152
-
-
70349684933
-
Prevalence of fatigue and depression in ALS patients and change over time
-
McElhiney, M. C., Rabkin, J. G., Gordon, P. H., Goetz, R. & Mitsumoto, H. Prevalence of fatigue and depression in ALS patients and change over time. J. Neurol. Neurosurg. Psychiatry 80, 1146-1149 (2009).
-
(2009)
J. Neurol. Neurosurg. Psychiatry
, vol.80
, pp. 1146-1149
-
-
McElhiney, M.C.1
Rabkin, J.G.2
Gordon, P.H.3
Goetz, R.4
Mitsumoto, H.5
-
153
-
-
84925872035
-
The evidence for symptomatic treatments in amyotrophic lateral sclerosis
-
Jenkins, T. M., Hollinger, H. & McDermott, C. J. The evidence for symptomatic treatments in amyotrophic lateral sclerosis. Curr. Opin. Neurol. 27, 524-531 (2014).
-
(2014)
Curr. Opin. Neurol.
, vol.27
, pp. 524-531
-
-
Jenkins, T.M.1
Hollinger, H.2
McDermott, C.J.3
-
154
-
-
13444274616
-
Modafinil to treat fatigue in amyotrophic lateral sclerosis: An open label pilot study
-
Carter, G. T. et al. Modafinil to treat fatigue in amyotrophic lateral sclerosis: An open label pilot study. Am. J. Hosp. Palliat. Care 22, 55-59 (2005).
-
(2005)
Am. J. Hosp. Palliat. Care
, vol.22
, pp. 55-59
-
-
Carter, G.T.1
-
155
-
-
62849083840
-
Modafinil treatment of fatigue in patients with ALS: A placebo-controlled study
-
Rabkin, J. G. et al. Modafinil treatment of fatigue in patients with ALS: A placebo-controlled study. Muscle Nerve 39, 297-303 (2009).
-
(2009)
Muscle Nerve
, vol.39
, pp. 297-303
-
-
Rabkin, J.G.1
-
156
-
-
84863111592
-
Interventions for fatigue and weight loss in adults with advanced progressive illness
-
Payne, C., Wiffen, P. J. & Martin, S. Interventions for fatigue and weight loss in adults with advanced progressive illness. Cochrane Database Syst. Rev. 1, CD008427 (2012).
-
(2012)
Cochrane Database Syst. Rev.
, vol.1
, pp. CD008427
-
-
Payne, C.1
Wiffen, P.J.2
Martin, S.3
-
157
-
-
84897929097
-
Neuromyelitis optica: Clinical features, immunopathogenesis and treatment
-
Jarius, S., Wildemann, B. & Paul, F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin. Exp. Immunol. 176, 149-164 (2014).
-
(2014)
Clin. Exp. Immunol.
, vol.176
, pp. 149-164
-
-
Jarius, S.1
Wildemann, B.2
Paul, F.3
-
158
-
-
84999127547
-
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis
-
Metz, I. et al. Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 3, e204 (2016).
-
(2016)
Neurol. Neuroimmunol. Neuroinflamm.
, vol.3
, pp. e204
-
-
Metz, I.1
-
160
-
-
84895076673
-
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
-
Trebst, C. et al. Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J. Neurol. 261, 1-16 (2014).
-
(2014)
J. Neurol.
, vol.261
, pp. 1-16
-
-
Trebst, C.1
-
161
-
-
79955737559
-
Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica
-
Chanson, J. B. et al. Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica. Eur. J. Neurol. 18, 836-841 (2011).
-
(2011)
Eur. J. Neurol.
, vol.18
, pp. 836-841
-
-
Chanson, J.B.1
-
162
-
-
84920582445
-
Current symptomatology in multiple sclerosis and neuromyelitis optica
-
Muto, M. et al. Current symptomatology in multiple sclerosis and neuromyelitis optica. Eur. J. Neurol. 22, 299-304 (2015).
-
(2015)
Eur. J. Neurol.
, vol.22
, pp. 299-304
-
-
Muto, M.1
-
163
-
-
85014646526
-
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder
-
Chavarro, V. S. et al. Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder. Neurol. Neuroimmunol. Neuroinflamm. 3, e286 (2016).
-
(2016)
Neurol. Neuroimmunol. Neuroinflamm.
, vol.3
, pp. e286
-
-
Chavarro, V.S.1
-
164
-
-
84959216202
-
Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: Anxiety, disability, fatigue and depression
-
Shi, Z. et al. Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: Anxiety, disability, fatigue and depression. J. Neuroimmunol. 293, 54-58 (2016).
-
(2016)
J. Neuroimmunol.
, vol.293
, pp. 54-58
-
-
Shi, Z.1
-
165
-
-
84929580984
-
Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica
-
Akaishi, T., Nakashima, I., Misu, T., Fujihara, K. & Aoki, M. Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica. J. Neuroimmunol. 283, 70-73 (2015).
-
(2015)
J. Neuroimmunol.
, vol.283
, pp. 70-73
-
-
Akaishi, T.1
Nakashima, I.2
Misu, T.3
Fujihara, K.4
Aoki, M.5
-
166
-
-
84977831621
-
Sleep abnormality in neuromyelitis optica spectrum disorder
-
Song, Y. et al. Sleep abnormality in neuromyelitis optica spectrum disorder. Neurol. Neuroimmunol. Neuroinflamm. 2, e94 (2015).
-
(2015)
Neurol. Neuroimmunol. Neuroinflamm.
, vol.2
, pp. e94
-
-
Song, Y.1
-
167
-
-
0036152780
-
Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: A two centre phase 2 study
-
Rammohan, K. W. et al. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: A two centre phase 2 study. J. Neurol. Neurosurg. Psychiatry 72, 179-183 (2002).
-
(2002)
J. Neurol. Neurosurg. Psychiatry
, vol.72
, pp. 179-183
-
-
Rammohan, K.W.1
-
168
-
-
20144389425
-
Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study
-
Stankoff, B. et al. Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study. Neurology 64, 1139-1143 (2005).
-
(2005)
Neurology
, vol.64
, pp. 1139-1143
-
-
Stankoff, B.1
-
169
-
-
80052010239
-
HAGIL (Hamburg Vigil Study): A randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis
-
Möller, F. et al. HAGIL (Hamburg Vigil Study): A randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis. Mult. Scler. 17, 1002-1009 (2011).
-
(2011)
Mult. Scler.
, vol.17
, pp. 1002-1009
-
-
Möller, F.1
-
170
-
-
67349149115
-
Modafinil effects in multiple sclerosis patients with fatigue
-
Lange, R., Volkmer, M., Heesen, C. & Liepert, J. Modafinil effects in multiple sclerosis patients with fatigue. J. Neurol. 256, 645-650 (2009).
-
(2009)
J. Neurol.
, vol.256
, pp. 645-650
-
-
Lange, R.1
Volkmer, M.2
Heesen, C.3
Liepert, J.4
-
171
-
-
0036038978
-
Modafinil in treatment of fatigue in multiple sclerosis
-
Zifko, U. A., Rupp, M., Schwarz, S., Zipko, H. T. & Maida, E. M. Modafinil in treatment of fatigue in multiple sclerosis. J. Neurol. 249, 983-987 (2002).
-
(2002)
J. Neurol.
, vol.249
, pp. 983-987
-
-
Zifko, U.A.1
Rupp, M.2
Schwarz, S.3
Zipko, H.T.4
Maida, E.M.5
-
172
-
-
33751402462
-
P300 and treatment effect of modafinil on fatigue in multiple sclerosis
-
Nagels, G. et al. P300 and treatment effect of modafinil on fatigue in multiple sclerosis. J. Clin. Neurosci. 14, 33-40 (2007).
-
(2007)
J. Clin Neurosci.
, vol.14
, pp. 33-40
-
-
Nagels, G.1
-
173
-
-
84958916709
-
Cognitive effects of modafinil in patients with multiple sclerosis: A clinical trial
-
Ford-Johnson, L. et al. Cognitive effects of modafinil in patients with multiple sclerosis: A clinical trial. Rehabil. Psychol. 61, 82-91 (2016).
-
(2016)
Rehabil. Psychol.
, vol.61
, pp. 82-91
-
-
Ford-Johnson, L.1
-
174
-
-
0842305087
-
Comparison of the effects of acetyl l carnitine and amantadine for the treatment of fatigue in multiple sclerosis: Results of a pilot, randomised, double-blind, crossover trial
-
Tomassini, V. et al. Comparison of the effects of acetyl l carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. J. Neurol. Sci. 218, 103-108 (2004).
-
(2004)
J. Neurol. Sci.
, vol.218
, pp. 103-108
-
-
Tomassini, V.1
-
175
-
-
16844368558
-
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
-
Wingerchuk, D. M. et al. A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis. Neurology 64, 1267-1269 (2005).
-
(2005)
Neurology
, vol.64
, pp. 1267-1269
-
-
Wingerchuk, D.M.1
-
176
-
-
84941287013
-
Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients
-
Pavsic, K., Pelicon, K., Ledinek, A. H. & Sega, S. Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients. Clin. Neurol. Neurosurg. 139, 35-40 (2015).
-
(2015)
Clin. Neurol. Neurosurg.
, vol.139
, pp. 35-40
-
-
Pavsic, K.1
Pelicon, K.2
Ledinek, A.H.3
Sega, S.4
-
177
-
-
84939256479
-
Sustained-released fampridine in multiple sclerosis: Effects on gait parameters, arm function, fatigue, and quality of life
-
Allart, E. et al. Sustained-released fampridine in multiple sclerosis: effects on gait parameters, arm function, fatigue, and quality of life. J. Neurol. 262, 1936-1945 (2015).
-
(2015)
J. Neurol.
, vol.262
, pp. 1936-1945
-
-
Allart, E.1
-
178
-
-
74249114595
-
Using modafinil to treat fatigue in Parkinson disease: A double-blind, placebo-controlled pilot study
-
Lou, J. S. et al. Using modafinil to treat fatigue in Parkinson disease: A double-blind, placebo-controlled pilot study. Clin. Neuropharmacol. 32, 305-310 (2009).
-
(2009)
Clin. Neuropharmacol.
, vol.32
, pp. 305-310
-
-
Lou, J.S.1
-
179
-
-
77951208074
-
Modafinil for Parkinson's disease fatigue
-
Tyne, H. L., Taylor, J., Baker, G. A. & Steiger, M. J. Modafinil for Parkinson's disease fatigue. J. Neurol. 257, 452-456 (2010).
-
(2010)
J. Neurol.
, vol.257
, pp. 452-456
-
-
Tyne, H.L.1
Taylor, J.2
Baker, G.A.3
Steiger, M.J.4
|